{
    "id": 26595,
    "fullName": "EGFR K739_I744dup",
    "impact": "duplication",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "EGFR K739_I744dup (also referred to as I744_K745insKIPVAI) indicates the insertion of six duplicate amino acids, lysine (K)-739 through isoleucine(I)-744, in the protein kinase domain of the Egfr protein (UniProt.org). K739_I744dup results in increased Egfr phosphorylation and is transforming in culture (PMID: 22190593).",
            "references": [
                {
                    "id": 439,
                    "pubMedId": 22190593,
                    "title": "EGFR exon 19 insertions: a new family of sensitizing EGFR mutations in lung adenocarcinoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/22190593"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 1956,
        "geneSymbol": "EGFR",
        "terms": [
            "EGFR",
            "ERBB",
            "ERBB1",
            "HER1",
            "mENA",
            "NISBD2",
            "PIG61"
        ]
    },
    "variant": "K739_I744dup",
    "createDate": "05/16/2017",
    "updateDate": "09/12/2018",
    "referenceTranscriptCoordinates": {
        "id": 135704,
        "transcript": "NM_005228",
        "gDna": "chr7:g.55174772_55174773insATCCCTGTAGCAATCAAG",
        "cDna": "c.2235_2236insATCCCTGTAGCAATCAAG",
        "protein": "p.I740_K745dupIPVAIK",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 10908,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical study, Iressa (gefitinib) demonstrated some efficacy in two patients with non-small cell lung cancer each harboring EGFR K739_I744dup (reported as I744_K745insKIPVAI), including a partial response in one patient and stable disease in the other patient (PMID: 28089594).",
            "molecularProfile": {
                "id": 27852,
                "profileName": "EGFR K739_I744dup"
            },
            "therapy": {
                "id": 751,
                "therapyName": "Gefitinib",
                "synonyms": null
            },
            "indication": {
                "id": 3908,
                "name": "lung non-small cell carcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 8924,
                    "pubMedId": 28089594,
                    "title": "Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-sensitive Exon 19 Insertion and Exon 20 Insertion in Patients With Advanced Non-Small-cell Lung Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28089594"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 10914,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical study, a patient with lung adenocarcinoma harboring EGFR K739_I744dup (reported as I744_K745insKIPVAI) demonstrated a partial response when treated with Tarceva (erlotinib) (PMID: 22190593).",
            "molecularProfile": {
                "id": 27852,
                "profileName": "EGFR K739_I744dup"
            },
            "therapy": {
                "id": 4,
                "therapyName": "Erlotinib",
                "synonyms": null
            },
            "indication": {
                "id": 3910,
                "name": "lung adenocarcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 439,
                    "pubMedId": 22190593,
                    "title": "EGFR exon 19 insertions: a new family of sensitizing EGFR mutations in lung adenocarcinoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/22190593"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 27852,
            "profileName": "EGFR K739_I744dup",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 135704,
            "transcript": "NM_005228",
            "gDna": "chr7:g.55174772_55174773insATCCCTGTAGCAATCAAG",
            "cDna": "c.2235_2236insATCCCTGTAGCAATCAAG",
            "protein": "p.I740_K745dupIPVAIK",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}